Skip to main content
Log in

Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background: The presence in bone marrow of cells which react with monoclonal antibodies against tumor-associated antigens has been proposed over the last few years as a new prognostic factor in breast cancer patients. Patients and methods: Bone marrow aspirates were obtained from 109 stage I and II breast cancer patients during or 2–4 weeks after primary surgery. The samples were processed for leukocyte separation on a Ficoll-Hypaque gradient and then used to prepare cytospin slides for immunocytochemical analysis. The slides were stained with a pool of monoclonal antibodies (MoAbs) which recognize tumor associated antigens, using the alkaline phosphatase anti-alkaline phosphatase method. The median follow-up was 36 months (range 15–62); 22 patients relapsed and 7 died. Results: Thirty-four of the 109 patients (31.1%) had MoAb positive bone marrow cells. The bone marrow was positive in 28/74 (37.9%) patients who had the aspirate taken during surgery and in 6/35 (17.1%) who had it taken after surgery (p = 0.055). No association was found between bone marrow positivity and tumour size, nodal status, menopausal status, estrogen receptor positivity or the proliferative index. No association was found between bone marrow and prognosis: the log-rank test was 0.291 (p > 0.5) for OS and 0.023 for DFS; the hazard ratio (positive vs negative) was 1.51 for OS (95% CI: 0.33–6.86) and 0.93 for DFS (95% CI: 0.35–2.45). Conclusions: In our series, bone marrow positivity did not correlate with prognostic parameters or prognosis. Of interest is the relative excess of positivity when the bone marrow was obtained during surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harris JR, Morrow M, Bonadonna G: Cancer of the breast. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice of Oncology, (ed 4). JB Lippincott, Philadelphia, 1993, chapter 40; 1264–1332

    Google Scholar 

  2. Coombes RC: The staging of human breast cancer: Physical staging techniques. In: Coombes RC, Powles YJ, Ford HT, Gazet JC (eds) Breast Cancer Management: The Experience of the Combined Breast Clinic, St. George's Hospital and the Royal Marsden Hospital. Academic Press, London, 1981, 77–95

    Google Scholar 

  3. Coombes RC, Dearmaley DP, Buckman R: Detection of bone metastases in patients with breast cancer. Invasion Metastasis 2: 177–184, 1982

    Google Scholar 

  4. McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE: Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147: 745–748, 1978

    Google Scholar 

  5. Salvadori B, Squicciarini P, Rovini D, Orefice S, Andreola S, Rilke F, Barletta L, Menard S, Colnaghi MI: Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 26(8): 865–867, 1990

    Google Scholar 

  6. Kirk SJ, Cooper GG, Hoper M, Watt PCH, Roy AD, Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481–485, 1990

    Google Scholar 

  7. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: Long-term follow-up of the first patient cohort. Eur J Cancer 27(3): 236–239, 1991

    Google Scholar 

  8. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27(12): 1552–1555, 1991

    Google Scholar 

  9. Cote RJ, Rosen PP, Old LJ, Osborne MP: Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol 1: 37–42, 1991

    Google Scholar 

  10. Osborne MP: Breast cancer micrometastases in bone marrow detected by fluorescein-labelled monoclonal antibodies: predictor of early relapse. Abstract. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda (USA), June 25, 1992

  11. Cote RJ: Detection and prognostic significance of occult bone marrow micrometastases in patients with early stage breast carcinoma. Abstract. Conference on cancer micrometastasis: Biology, Methodology, and clinical significance. Bethesda (USA), June 25, 1992

  12. Schlimok F, Lindemann F, Holzmann K, Witte J, Renner D, Riethmuller G: Prognostic significance of disseminated tumor cells detected in bone marrow of patients with breast and colorectal cancer: a multivariate analysis. Abstract. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda (USA), June 25, 1992

  13. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10(10): 1534–1539, 1992

    Google Scholar 

  14. Merkle E, Henke A, Bahr I, Buhner M, Lang N: Tumor cell detection in bone marrow of primary breast cancer patients. Abstract. 18th International Congress of Chemotherapy. Stockholm Sweden pg 322, June 27–July 2, 1993

  15. Harbeck N, Untch M, Pache L, Eiermann W: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566–571, 1994

    Google Scholar 

  16. Menard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer 69: 1126–1129, 1994

    Google Scholar 

  17. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes C, Neville M: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1–6, 1988

    Google Scholar 

  18. Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Corgnati A, Sperotto L, Martignoni G, Bonetti A, Nortilli R, Castelli P, Rodella S, Capelli P, Manfrin E, Pelosi Cetto GL: Estrogen receptors in 699 primary breast cancer: A comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat 34: 221–228, 1995

    Google Scholar 

  19. Tagliabue E, Porro G, Barbanti P, Della Torre G, Menard S, Rilke F, Colnaghi MI: Improvement of tumor cell detection using a pool of monoclonal antibodies. Hybridoma 5: 107–115, 1986

    Google Scholar 

  20. Molino A, Colombatti M, Bonetti F, Zardini M, Pasini F, Perini A, Pelosi G, Tridente G, Veneri D, Cetto GL: A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 67(4): 1033–1036, 1991

    Google Scholar 

  21. Pelosi G, Bresaola E, Manfrin E, Rodella S, Schiavon I, Iannucci A: Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human neoplasms using PC10, reactive with proliferating cell nuclear antigen (PCNA) and Ki67: a comparative study. Arch Pathol Lab Med 118: 510–516, 1994

    Google Scholar 

  22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958

    Google Scholar 

  23. Cox DR: Regression model and life tables (with discussion). J Roy Stat Soc (B) 34: 187–220, 1972

    Google Scholar 

  24. Breslow N: Covariance analysis of censored survival data. Biometrics 30: 89–99, 1974

    Google Scholar 

  25. Dixon WJ: BMDP statistical software. University of California Press, Berkeley 1988

    Google Scholar 

  26. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles T, Coombes RC: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093, 1987

    Google Scholar 

  27. Diel I, Kaufmann M, Krempien B, Kaul S, Gorner R, Costa S, Bastert G: Immunocytochemical detection of tumor cells in bone marrow in patients with primary breast cancer. Br J Cancer 62(suppl 12): 3, 1990

    Google Scholar 

  28. Osborne MP, Wong GY, Cote RJ, Liu J, Potter C, Killackey D, Old LJ, Rosen PP: Breast cancer micrometastases in bone marrow: detection by fluorescein-labeled monoclonal antibodies predicts early relapse. Abstract. Proceedings of ASCO 10: A53, 1991

    Google Scholar 

  29. Menard S: Bone marrow micrometastases in breast cancer: correlation with the tumor biology. Conference on cancer micrometastasis: biology, metodology, and clinical significance. Abstract. Bethesda (USA), June 25, 1992

  30. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9(10): 1749–1756, 1991

    Google Scholar 

  31. Diel LJ, Kaufmann M, Solomayer EF, Costa SD, Gruber-Hoffmann B, Kaul S, Bastert G: Micrometastatic tumor cells in bone marrow versus nodal status in breast cancer-impact on prognosis in patients with primary breast cancer. Abstract. Proceedings of ASCO 14: 110, 1995

    Google Scholar 

  32. Singhal H, Cote RJ, Potter C, Osborne MP: Bone marrow micrometastases in breast cancer: relationship to local-regional disease status. Abstract. Proceedings of ASCO 13: A215, 1994

    Google Scholar 

  33. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82(9): 2605–2610, 1993

    Google Scholar 

  34. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83(3): 636–640, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molino, A., Pelosi, G., Turazza, M. et al. Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42, 23–30 (1997). https://doi.org/10.1023/A:1005747711084

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005747711084

Navigation